Novo Nordisk has announced that the Endocrinologic and Metabolic Drugs Advisory Committee (EMDAC) of the US Food and Drug Administration (FDA) voted 16-0, recommending the
As reported by Reuters, tiny Israeli drugmaker Oramed Pharmaceuticals Inc on Wednesday said its experimental oral insulin succeeded in significantly reducing night-time blood glucose in
Sanofi will focus less on diabetes monitoring devices, Chief Executive Officer Olivier Brandicourt said at the end of October (2015) after projecting disappointing sales for
See our latest issue for a feature on fab new bits of diabetes management equipment that’s coming soon in 2015, as well as some insights
As well as recipes, the new IDDT recipe book, Diabetes – Food, Meds and More, has an emphasis on lifestyle, a focus on real life,
Our newest issue takes a look at the hassles of handling diabetes when you undertake sport or exercise. It’s dreadfully off-putting to consider that by
As reported by Elie Dolgin in Nature magazine, insulin-producing islet cells could hold the secret to curing Type 1 diabetes, if only scientists could figure
In our latest issue we’ve talked to Dr. Jen Nash, a clinical psychologist who has Type 1 diabetes. She offers some handy hints on how
As reported in Diabetes Health, DV-100, a drug designed to halt the body’s autoimmune attack on pancreatic beta cells that leads to type 1 disease,
In December AstraZeneca announced an agreement under which it will acquire the entirety of Bristol-Myers Squibb’s interests in the companies’ diabetes alliance for an initial
